Economy
Thailand Targets 100 Billion Baht Investment from Global Pharmaceutical Giants
The Thai Ministry of Public Health is negotiating with major international pharmaceutical companies to establish research and production facilities in Thailand.
According to a report by Thai Post on September 12, 2026, the Thai government is actively courting global pharmaceutical leaders to invest in the country’s medical sector. Government spokespeople confirmed that successful negotiations have already taken place with MSD and Roche, with ongoing discussions involving Sandoz and several other international firms.
The initiative aims to secure a total investment of 100 billion baht dedicated to research and development. The goal is to integrate Thailand into the global supply chain for the development and manufacturing of new medications.
For residents and long-term visitors, this development may signal a strengthening of Thailand’s medical infrastructure and potential improvements in the local availability of advanced pharmaceutical treatments. However, the project is currently in the negotiation phase. Specific timelines for the construction of facilities, the types of medications to be produced, and the final confirmation of the total investment figures remain to be determined. As the government continues its outreach to additional pharmaceutical companies, further details regarding the scope and impact of these partnerships are expected to emerge.
